The global Immuno-oncology Drugs market is estimated to be valued at US$ 17,394.2 million in 2023 and is expected to exhibit a CAGR of 16.8% over the forecast period 2023-2030.
A) Market Overview:
Immuno-oncology Drugs are an emerging class of cancer therapeutics that harness the body's immune system to fight cancer. These drugs stimulate the immune system to recognize...
0 Commentarios
0 Acciones
2349 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian